Record citatie

APA (7e ed.) Bronvermelding
Sekikawa, M., Murakami, H., Morita, M., Doshita, K., Miura, K., Kodama, H., . . . Takahashi, T. (2023). Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer. Wiley.
Chicago (17e ed.) Bronvermelding
Sekikawa, Motoki, et al. Safety and Efficacy of Amrubicin with Primary Prophylactic Pegfilgrastim as Second‐line Chemotherapy in Patients with Small Cell Lung Cancer. Wiley, 2023.
MLA (9e ed.) Bronvermelding
Sekikawa, Motoki, et al. Safety and Efficacy of Amrubicin with Primary Prophylactic Pegfilgrastim as Second‐line Chemotherapy in Patients with Small Cell Lung Cancer. Wiley, 2023.
Let op: Deze citaties zijn niet altijd 100% accuraat.